Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General · United States

Last price 165.61 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 205.35B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an inj...